Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC — Stella

Recruiting

Back to Primary Sclerosing Cholangitis trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

University of Minnesota, Minneapolis, Minnesota

Key details

Phase

Very early testing

Sponsor

University of Minnesota

Enrollment target

~28 participants

Started

March 2024

Primary completion

March 2027

Age range

18 Years – 76 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov